Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
eLife · 26.05.2023 · 12
DOI: 10.7554/elife.86014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift eLife, online erschienen am 26.05.2023. Verfasst von Sindhu Mohandas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, United Sta…. Hauptthemen laut MEDLINE: COVID-19, Post-Acute COVID-19 Syndrome. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
With a global tally of more than 500 million cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections to date, there are growing concerns about the post-acute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID. Recent studies suggest that exaggerated immune responses are key determinants of the severity and outcomes of the initial SARS-CoV-2 infection as well as subsequent PASC. The complexity of the innate and adaptive immune responses in the acute and post-acute period requires in-depth mechanistic analyses to identify specific molecular signals as well as specific immune cell populations which promote PASC pathogenesis. In this review, we examine the current literature on mechanisms of immune dysregulation in severe COVID-19 and the limited emerging data on the immunopathology of PASC. While the acute and post-acute phases may share some parallel mechanisms of immunopathology, it is likely that PASC immunopathology is quite distinct and heterogeneous, thus requiring large-scale longitudinal analyses in patients with and without PASC after an acute SARS-CoV-2 infection. By outlining the knowledge gaps in the immunopathology of PASC, we hope to provide avenues for novel research directions that will ultimately lead to precision therapies which restore healthy immune function in PASC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, United States.
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, United States.
- Division of Experimental Medicine, University of California, San Francisco, San Francisco, United States.
- Department of Biochemistry & Molecular Biology, Howard University College of Medicine, Washington, United States.
- Division of Pulmonary, Allergy, Critical Care & Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, United States.
- National Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, United States.
ORCID-Profile: Sindhu Mohandas, Prasanna Jagannathan, Zaki A Sherif, Jalees Rehman
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Mohandas, S., Jagannathan, P., Henrich, T. J., Sherif, Z. A., Bime, C., Quinlan, E., Portman, M. A., Gennaro, M., Rehman, J., & RECOVER Mechanistic Pathways Task Force (2023). Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC). eLife, 12. https://doi.org/10.7554/elife.86014
Vancouver
Mohandas S, Jagannathan P, Henrich TJ, Sherif ZA, Bime C, Quinlan E, et al. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC). eLife. 2023;12. doi:10.7554/elife.86014
BibTeX
@article{Mohandas2023,
author = {Mohandas, Sindhu and Jagannathan, Prasanna and Henrich, Timothy J and Sherif, Zaki A and Bime, Christian and Quinlan, Erin and Portman, Michael A and Gennaro, Marila and Rehman, Jalees and RECOVER Mechanistic Pathways Task Force, RECOVER Mechanistic Pathways Task Force},
title = {Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.86014}
}
EUVIMED